Last updated on February 2018

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia


Brief description of study

This is a single arm, open-label, multi-center study to determine the efficacy and safety of an experimental therapy called CART-19 in patients with chemo-refractory and relapsed B-cell ALL.

Detailed Study Description

This is a single arm, open-label, multi-center, phase I study to determine the efficacy of CTL019 in patients with r/r B-cell ALL. The study will have the following sequential phases: Screening, Pre-Treatment (Cell Product Preparation & Lymphodepleting Chemotherapy), Treatment and Primary Follow-up, Secondary Follow-up (if applicable) and Survival Follow-up.

Clinical Study Identifier: NCT02810223

Contact Investigators or Research Sites near you

Start Over

Peng Shicheng

First Affiliated Hospital of Henan University of Science and Technology
Luoyang, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.